Kanagawa, Japan

Masaharu Shiga


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Masaharu Shiga: Innovator in Diabetic Neuropathy Treatment

Introduction

Masaharu Shiga is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical treatments, particularly in addressing diabetic neuropathy. His innovative approach has led to the development of a unique method that enhances nerve function in patients suffering from this condition.

Latest Patents

Masaharu Shiga holds a patent for a method of treatment for diabetic neuropathy. This method involves the combined administration of a formulation that includes a prostaglandin I derivative, specifically a prostaglandin I2 derivative, along with an anti-diabetic agent. This treatment is particularly effective for hypofunction of motor and sensory nerves, which are often inadequately addressed by conventional anti-diabetic agents. The application of this method has shown improvements in nerve conduction velocities, offering hope to those affected by diabetic neuropathy. He has 1 patent to his name.

Career Highlights

Shiga is currently associated with Toray Industries, Inc., where he continues to work on innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in advancing treatment methodologies for diabetic conditions.

Collaborations

Throughout his career, Masaharu Shiga has collaborated with esteemed colleagues such as Tasuku Okamoto and Koji Miyata. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of effective treatments.

Conclusion

Masaharu Shiga's contributions to the treatment of diabetic neuropathy exemplify the impact of innovation in medicine. His work not only addresses a critical health issue but also showcases the importance of collaboration in advancing medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…